The road to effective and accessible antibody therapies against Ebola virus

Keyphrases

• Antibody Protein 20%
• Antibody Therapy 100%
• Clinical Trials 20%
• Cripple 20%
• Ebola Outbreak 20%
• Ebola Virus 100%
• Health Systems 20%
• Individual Survival 20%
• Infectious Agents 20%
• Local Economy 20%
• Monoclonal Antibody 40%
• Preclinical Development 20%
• System Economy 20%
• Viremia 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Trial 16%
• Diseases 16%
• Ebola Virus 100%
• Immunoglobulin 16%
• Immunotherapy 50%
• Infectious Agent 16%
• Monoclonal Antibody 33%
• Viremia 16%

Immunology and Microbiology

• Ebola Virus 100%
• Immunotherapy 50%
• Infectious Agent 16%
• Intravenous Immunoglobulin 16%
• Monoclonal Antibody 33%
• Preclinical Study 16%
• Viremia 16%